Newsletter

Newsletter

Abnormal Kidney Disease Markers Associated With Increased Mortality Risk

Life Extension Featured Article

May 21, 2010

Abnormal kidney disease markers associated with increased mortality risk over 8 year average period

Abnormal kidney disease markers associated with increased mortality risk over 8 year average period

A meta-analysis conducted by the Chronic Kidney Disease Prognosis Consortium published on May 18, 2010 in The Lancet concluded that elevations in urinary albumin and albumin to creatinine ratio, which indicate kidney damage, as well as a reduction in the estimated glomerular filtration rate (eGFR) of the kidneys predict an increased risk of death from all causes over 2.1 to 11.6 years of follow-up.

The Consortium, which was established in 2009 by KDIGO (Kidney Disease: Improving Global Outcomes), selected 21 studies including a total of 1,234,182 participants from 14 countries for their analysis. Over the follow-up periods, 45,584 deaths occurred.

When the rate at which the glomerulii of the kidneys filter the blood dropped below a specific level, a greater risk of dying over follow-up occurred, which increased with declining rates. Additionally, an increase in albumin, a protein that is elevated in the urine when the kidneys are damaged, and a greater ratio of urinary albumin to creatinine (a product of creatine breakdown) were associated with significantly increased all-cause mortality risk. A similar elevation in risk was observed for deaths from cardiovascular disease. "eGFR less than 60 mL/min/1.73 m2 and albumin to creatinine ratio 10 mg/g or more are independent predictors of mortality risk in the general population," the authors conclude. "This study provides quantitative data for use of both kidney measures for risk assessment and definition and staging of chronic kidney disease."

"People with high levels of albumin in their urine were at markedly higher risk of mortality than people with low levels of albumin in the urine," noted lead author Kunihiro Matsushita, MD, PhD, who is a postdoctoral fellow with the Johns Hopkins Bloomberg School of Public Health's Department of Epidemiology. "The risk of mortality was elevated by nearly 50 percent at 30 mg/gram albumin to creatinine ratio, which is the threshold for defining chronic kidney disease. In addition, mortality risk increased more than four-fold at high levels of albuminuria compared to an optimal level of 5 mg/gram. The data presented in this analysis confirm that the current thresholds are indicative of increased all-cause and cardiovascular mortality risk with both kidney filtration function and urine protein contributing to risk."

Printer Friendly Save as PDF Email this Page View Archive Subscribe Today
Health Concern

Chronic kidney disease

You may be surprised to learn that until 2002, no standard definition for chronic kidney disease (CKD) existed within the medical community. Before then, conflicting classifications had created a state of confusion as to how many Americans were afflicted with this progressive, life-threatening condition.

Life Extension® has long emphasized the need for vigilance through regular testing (at least once a year) to monitor kidney health. In addition to the standard tests for creatinine, albumin, and BUN/creatinine ratio, certain individuals should insist their doctor test for cystatin-C, a largely overlooked blood marker which provides a far more precise measure of renal function. Optimal levels are less than .91 mg/L.

Individuals should also keep a record of their test results. Once any sign of disease is detected (such as an increase in creatinine), it is imperative that immediate steps be taken to halt its progress, as kidney function can decline precipitously and may be irreversible. Fortunately, many Life Extension® customers are already taking a variety of nutrients that support kidney health.

Featured Products

European Leg Solution featuring Certified Diosmin 95

add to cart

Six ways Life Extension®’s European Leg Solution featuring Certified Diosmin 95 works for you:

  • Maintains healthy blood flow through your capillaries—the most fragile of your blood vessels.
  • Maintains tone and elasticity of your veins—the key to sustained vascular health.
  • Eases the inflammatory effects of free-floating biochemical compounds.
  • Safeguards collagen and elastin against oxidative damage.
  • Enjoys an outstanding safety record.
  • Produces results in just 1-2 weeks, with a single 600 mg tablet taken each morning.

Super Ginkgo Extract 28/7

add to cart

Ginkgo contains numerous antioxidants such as proanthocyanidins and flavonoids that counteract free radical activity. Flavonoids are also known to strengthen capillaries, which can promote healthy blood flow to the brain to help maintain cognitive health. Ginkgo may:

  • Help maintain normal circulation by dilating blood vessels and reducing the stickiness of blood platelets
  • Help maintain the normal function and tone of blood vessels, and maintain a normal blood flow
  • Maintain already normal oxygen and glucose metabolism in the brain
  • Maintain normal coagulation of blood
  • Help slow the aging process in the brain
  • Ginkgo biloba extract is reputed as a neuroprotective antioxidant agent.
News Archive

Life Extension Update

What's Hot

Life Extension Magazine®

If you have questions or comments concerning this issue or past issues of Life Extension Update, send them to ddye@lifeextension.com or call 1-800-678-8989.

www.lifeextension.com
Sign up for Life Extension Update

For copyright permission, please refer to Life Extension copyright policy.

For Customer Service inquiries, please email customerservice@lifeextension.com or call 1 800 678 8989.